Literature DB >> 6274394

Two contiguous thrombin fragments of human somatotropin form a functionally active recombinant, but the two homologous fragments from sheep hormone do not.

L Gráf, C H Li, C H Cheng, M D Jibson.   

Abstract

Two thrombin fragments of reduced-carbamidomethylated human somatotropin representing the full primary structure of the native hormone (residues 1-134 and 135-191) have been found to form a recombinant molecule with properties similar to those of reduced-carbamidomethylated human somatotropin as shown by circular dichroism spectroscopy, two receptor-binding assays, and radioimmunoassay. In contrast, the homologous thrombin fragments of reduced-carbamidomethylated sheep hormone (residues 1-133 and 134-191) do not undergo recombination. Furthermore, neither the reduced-alkylated nor the reduced and nonalkylated C-terminal thrombin fragment of sheep hormone is able to interact with the reduced-carbamidomethylated N-terminal thrombin fragment of human hormone, under conditions which favor the recombination of the two human somatotropin fragments.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274394     DOI: 10.1021/bi00528a031

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

Authors:  I Struman; F Bentzien; H Lee; V Mainfroid; G D'Angelo; V Goffin; R I Weiner; J A Martial
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

2.  A new non-covalent complex of semisynthetically modified tryptic fragments of cytochrome c.

Authors:  A E Proudfoot; C J Wallace; D E Harris; R E Offord
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

3.  A case of spurious product formation during attempted resynthesis of proteins by reverse proteolysis. Some batches of 'pure' glycerol contain cross-linking agents.

Authors:  A E Proudfoot; R E Offord; K Rose; M Schmidt; C J Wallace
Journal:  Biochem J       Date:  1984-07-15       Impact factor: 3.857

4.  Antigenic, receptor-binding and mitogenic activity of proteolytic fragments of human growth hormone.

Authors:  R Aston; J Ivanyi
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.